Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ADAM12 |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → ADAM12 |
| (<<) CASP1 → ADAM12 |
| (<<) CAV1 → ADAM12 |
| (<<) CDH11 → ADAM12 |
| (<<) CLEC2B → ADAM12 |
| (<<) CORO1A → ADAM12 |
| (<<) CTGF → ADAM12 |
| (<<) CYR61 → ADAM12 |
| (<<) FZD7 → ADAM12 |
| (<<) MAPK1 → ADAM12 |
| (<<) MMP2 → ADAM12 |
| (<<) NNMT → ADAM12 |
| (<<) RECK → ADAM12 |
| (<<) SCG5 → ADAM12 |
| (<<) TCF4 → ADAM12 |
| (<<) VIM → ADAM12 |
| Downstream (Children) |
|---|
| ADAM12 → ANTXR1 (>>) |
| ADAM12 → CDKN2A (>>) |
| ADAM12 → CYP1A2 (>>) |
| ADAM12 → CYP1B1 (>>) |
| ADAM12 → ELF5 (>>) |
| ADAM12 → F2RL1 (>>) |
| ADAM12 → FGF1 (>>) |
| ADAM12 → GPNMB (>>) |
| ADAM12 → GPX7 (>>) |
| ADAM12 → HIF1A (>>) |
| ADAM12 → HLA-DOA (>>) |
| ADAM12 → HMOX1 (>>) |
| ADAM12 → INHBA (>>) |
| ADAM12 → ISLR (>>) |
| ADAM12 → MMP1 (>>) |
| ADAM12 → MMP7 (>>) |
| ADAM12 → MN1 (>>) |
| ADAM12 → MXRA8 (>>) |
| ADAM12 → PCK2 (>>) |
| ADAM12 → PLAU (>>) |
| ADAM12 → STK17B (>>) |
| ADAM12 → SULF1 (>>) |
| ADAM12 → THY1 (>>) |
| ADAM12 → TMEM158 (>>) |
| ADAM12 → TNC (>>) |
| ADAM12 → TNFRSF11A (>>) |
